JJ
Jyoti Jaiswal
About Jyoti Jaiswal
Data last updated:
Jyoti Jaiswal is a Managing Director at Human Biolife India Private Limited (since 2014), Director at Nexwin Pharma Private Limited (since 2020) and Director at Sparkbless Pharma Private Limited (since 2021). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹26.04 Cr; the largest is Human Biolife India Private Limited at ₹21.15 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 23 Dec 2014 | 2014 | ₹21.15 Cr (FY 2023) | Active | |
| Director | 31 Aug 2020 | 2020 | ₹4.89 Cr (FY 2024) | Active | |
| Director | 22 Oct 2021 | 2021 | Active |
Board colleagues of Jyoti Jaiswal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kali Charan Jaiswal | 07043502 | Human Biolife India Private Limited , Nexwin Pharma Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jyoti Jaiswal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jyoti Jaiswal
Jyoti Jaiswal currently holds 3 directorships: Human Biolife India Private Limited (Managing Director, since 23 Dec 2014, revenue ₹21.15 Cr (FY 2023)); Nexwin Pharma Private Limited (Director, since 31 Aug 2020, revenue ₹4.89 Cr (FY 2024)); Sparkbless Pharma Private Limited (Director, since 22 Oct 2021).
Jyoti Jaiswal was first appointed on 23 Dec 2014 as Managing Director at Human Biolife India Private Limited. The most recent appointment on record is 22 Oct 2021 at Sparkbless Pharma Private Limited.
The 2 current companies of Jyoti Jaiswal that report revenue have a combined latest revenue of ₹26.04 Cr: Human Biolife India Private Limited ₹21.15 Cr (FY 2023); Nexwin Pharma Private Limited ₹4.89 Cr (FY 2024).
The current boards of Jyoti Jaiswal's companies include Kali Charan Jaiswal (Human Biolife India Private Limited).